Mecolzine

Mesalazine, the active ingredient in Mecolzine, is a 5‑aminosalicylic acid (5‑ASA) anti‑inflammatory presented as a rectal formulation for rectal use. It is employed to treat ulcerative colitis, particularly inflammation limited to the rectum and distal colon, in adult patients.

GNH USA supplies Mecolzine as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to EU quality standards and provides regulatory‑compliant shipments to global markets.

Mecolzine (mesalazine) is used in the management of inflammatory bowel disease, specifically ulcerative colitis, acting locally on the colonic mucosa.

- Ulcerative colitis: reduces mucosal inflammation and promotes remission in patients with disease limited to the rectum or left colon. - Ulcerative proctitis: delivers topical anti‑inflammatory effect to control symptoms and heal the rectal lining. - Maintenance of remission: helps sustain disease‑free status after induction therapy in ulcerative colitis.

Mecolzine may cause a range of adverse reactions, most of which are mild and self‑limiting.

Common Side Effects: - Rectal irritation or burning sensation. - Abdominal cramping or pain. - Diarrhoea or loose stools. - Nausea. - Headache. - Mild skin rash.

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis, angioedema). - Hepatotoxicity (elevated liver enzymes, jaundice). - Blood dyscrasias (neutropenia, thrombocytopenia). - Acute pancreatitis. - Renal impairment or interstitial nephritis. - Severe colitis flare requiring hospitalization.

Before initiating Mecolzine, consider the following safety measures.

- Renal function: assess baseline kidney function and monitor periodically. - Hepatic status: evaluate liver enzymes prior to treatment and during therapy. - Blood counts: obtain complete blood count before start and monitor for cytopenias. - Pregnancy: use only if potential benefit justifies potential risk; data are limited. - Breastfeeding: weigh benefits against possible infant exposure. - Storage: Store at room temperature: keep in original container, protect from moisture and direct sunlight.

Mecolzine can interact with other medicines, altering efficacy or safety.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): may increase bleeding risk. - High‑dose NSAIDs: can exacerbate renal toxicity.

Moderate Interactions (Monitor Closely): - Other 5‑ASA products: risk of additive toxicity. - Corticosteroids: may increase risk of gastrointestinal side effects. - Immunosuppressants (e.g., azathioprine): monitor for enhanced myelosuppression.